High Grade Endometrioid Cancer

1 clinical trials · Condition

Record	Firm	Date
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor (NCT05065021)	University Health Network, Toronto	2023-02-23

Every clearance here is in the API, with alerts when new ones post.